Matrix metalloproteinase-9 expression and release from skin fibroblasts interacting with keratinocytes: Upregulation in response to sulphur mustard

Toxicology

Volumn 263, Issue 1, 2009, Pages 26-31

  Ries, Christian ^a   Popp, Tanja ^a   Egea, Virginia ^a   Kehe, Kai ^b   Jochum, Marianne ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b BUNDESWEHR INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (Germany)

Author keywords

Cell migration and invasion; Coculture; Gelatinase B; MMP 9; Reconstituted skin model; Sulphur mustard

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE 14; MUSTARD GAS; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; CELL INVASION; CELL MIGRATION; COCULTURE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; NEWBORN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SKIN FIBROBLAST; UPREGULATION; WOUND HEALING;

CELL LINE; CELL MOVEMENT; CHEMICAL WARFARE AGENTS; COCULTURE TECHNIQUES; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFANT, NEWBORN; KERATINOCYTES; MATRIX METALLOPROTEINASE 9; MUSTARD GAS; RNA, MESSENGER; SKIN; SKIN, ARTIFICIAL; UP-REGULATION; WOUND HEALING;

EID: 67849113956     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2008.08.011     Document Type: Article

References (36)

1. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., and Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106 (1988) 761-771
2. Buth H., Wolters B., Hartwig B., Meier-Bornheim R., Veith H., Hansen M., Sommerhoff C.P., Schaschke N., Machleidt W., Fusenig N.E., Boukamp P., and Brix K. HaCaT keratinocytes secrete lysosomal cysteine proteinases during migration. Eur. J. Cell Biol. 83 (2004) 781-795
3. Chen T., Kunnavatana S.S., and Koch R.J. Effects of mitomycin-C on normal dermal fibroblasts. Laryngoscope 116 (2006) 514-517
4. Cowan F.M., and Broomfield C.A. Putative roles of inflammation in the dermatopathology of sulfur mustard. Cell Biol. Toxicol. 9 (1993) 201-213
5. Cowan F.M., Yourick J.J., Hurst C.G., Broomfield C.A., and Smith W.J. Sulfur mustard-increased proteolysis following in vitro and in vivo exposures. Cell Biol. Toxicol. 9 (1993) 269-277
6. Goetzl E.J., Banda M.J., and Leppert D. Matrix metalloproteinases in immunity. J. Immunol. 156 (1996) 1-4
7. Hu J., Van den Steen P.E., Sang Q.X., and Opdenakker G. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat. Rev. Drug Discov. 6 (2007) 480-498
8. Itoh Y., and Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J. Cell. Physiol. 206 (2006) 1-8
9. Kehe K., and Szinicz L. Medical aspects of sulphur mustard poisoning. Toxicology 214 (2005) 198-209
10. Korkmaz B., Moreau T., and Gauthier F. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions. Biochimie 90 (2008) 227-242
11. Lindsay C.D., Gentilhomme E., and Mathieu J.D. The use of doxycycline as a protectant against sulphur mustard in HaCaT cells. J. Appl. Toxicol. 28 (2008) 665-673
12. Liu Z., Shipley J.M., Vu T.H., Zhou X., Diaz L.A., Werb Z., and Senior R.M. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J. Exp. Med. 188 (1998) 475-482
13. Maas-Szabowski N., Shimotoyodome A., and Fusenig N.E. Keratinocyte growth regulation in fibroblast cocultures via a double paracrine mechanism. J. Cell Sci. 112 Pt 12 (1999) 1843-1853
14. Moll U.M., Youngleib G.L., Rosinski K.B., and Quigley J.P. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res. 50 (1990) 6162-6170
15. Nagase H., and Woessner J.F. Matrix metalloproteinases. J. Biol. Chem. 274 (1999) 21491-21494
16. Neth P., Ciccarella M., Egea V., Hoelters J., Jochum M., and Ries C. Wnt signaling regulates the invasion capacity of human mesenchymal stem cells. Stem Cells 24 (2006) 1892-1903
17. Nguyen M., Arkell J., and Jackson C.J. Human endothelial gelatinases and angiogenesis. Int. J. Biochem. Cell Biol. 33 (2001) 960-970
18. Oberringer M., Meins C., Bubel M., and Pohlemann T. In vitro wounding: effects of hypoxia and transforming growth factor beta1 on proliferation, migration and myofibroblastic differentiation in an endothelial cell-fibroblast co-culture model. J. Mol. Histol. 39 (2008) 37-47
19. Parks W.C., Wilson C.L., and Lopez-Boado Y.S. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol. 4 (2004) 617-629
20. Powers J.C., Kam C.M., Ricketts K.M., and Casillas R.P. Cutaneous protease activity in the mouse ear vesicant model. J. Appl. Toxicol. 20 Suppl. 1 (2000) S177-S182
21. Ravanti L., and Kahari V.M. Matrix metalloproteinases in wound repair (review). Int. J. Mol. Med. 6 (2000) 391-407
22. Ries C., Egea V., Karow M., Kolb H., Jochum M., and Neth P. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Blood 109 (2007) 4055-4063
23. Ries C., Pitsch T., Mentele R., Zahler S., Egea V., Nagase H., and Jochum M. Identification of a novel 82 kDa proMMP-9 species associated with the surface of leukaemic cells: (auto-)catalytic activation and resistance to inhibition by TIMP-1. Biochem. J. 405 (2007) 547-558
24. Sabourin C.L., Danne M.M., Buxton K.L., Casillas R.P., and Schlager J.J. Cytokine, chemokine, and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin. J. Biochem. Mol. Toxicol. 16 (2002) 263-272
25. Sadeghi H.M., Seitz B., Hayashi S., LaBree L., and McDonnell P.J. In vitro effects of mitomycin-C on human keratocytes. J. Refract. Surg. 14 (1998) 534-540
26. Sawicki G., Marcoux Y., Sarkhosh K., Tredget E.E., and Ghahary A. Interaction of keratinocytes and fibroblasts modulates the expression of matrix metalloproteinases-2 and -9 and their inhibitors. Mol. Cell. Biochem. 269 (2005) 209-216
27. Shakarjian M.P., Bhatt P., Gordon M.K., Chang Y.C., Casbohm S.L., Rudge T.L., Kiser R.C., Sabourin C.L., Casillas R.P., Ohman-Strickland P., Riley D.J., and Gerecke D.R. Preferential expression of matrix metalloproteinase-9 in mouse skin after sulfur mustard exposure. J. Appl. Toxicol. 26 (2006) 239-246
28. Shimanovich I., Mihai S., Oostingh G.J., Ilenchuk T.T., Brocker E.B., Opdenakker G., Zillikens D., and Sitaru C. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J. Pathol. 204 (2004) 519-527
29. Stuelten C.H., DaCosta B.S., Arany P.R., Karpova T.S., Stetler-Stevenson W.G., and Roberts A.B. Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-alpha and TGF-beta. J. Cell Sci. 118 (2005) 2143-2153
30. Van den Steen P.E., Dubois B., Nelissen I., Rudd P.M., Dwek R.A., and Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37 (2002) 375-536
31. Van-den-Steen P.E., Proost P., Wuyts A., Van-Damme J., and Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 96 (2000) 2673-2681
32. Westermarck J., and Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13 (1999) 781-792
33. Witte M.B., Thornton F.J., Kiyama T., Efron D.T., Schulz G.S., Moldawer L.L., and Barbul A. Metalloproteinase inhibitors and wound healing: a novel enhancer of wound strength. Surgery 124 (1998) 464-470
34. Woessner Jr. J.F., Dannenberg Jr. A.M., Pula P.J., Selzer M.G., Ruppert C.L., Higuchi K., Kajiki A., Nakamura M., Dahms N.M., and Kerr J.S. Extracellular collagenase, proteoglycanase and products of their activity, released in organ culture by intact dermal inflammatory lesions produced by sulfur mustard. J. Invest. Dermatol. 95 (1990) 717-726
35. Wormser U., Brodsky B., and Reich R. Topical treatment with povidone iodine reduces nitrogen mustard-induced skin collagenolytic activity. Arch. Toxicol. 76 (2002) 119-121
36. Yu Q., and Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 14 (2000) 163-176